FilingReader Intelligence

Genky DrugStores plans 200m yen restricted stock plan

August 19, 2025 at 12:19 AM UTCBy FilingReader AI

Genky DrugStores plans to introduce a restricted stock compensation system for directors, requiring shareholder approval at its September 2025 annual meeting.

The proposal seeks approval for up to 200 million yen in restricted stock remuneration annually, separate from existing director compensation limits. The system will be capped at 100,000 shares per year, with share prices based on Tokyo Stock Exchange closing prices.

Directors will face transfer restrictions preventing them from selling, pledging or disposing of shares during specified periods.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

TSE:9267Tokyo Stock Exchange

News Alerts

Get instant email alerts when Genky Drugstores publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →